Congress Adopts New User Fee Program

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-02-2002
Volume 26
Issue 7

To fund expanded FDA operations designed to streamline drug development and approval, FDA and industry representatives have negotiated the Prescription Drug User Fee Act III.

Recent Videos
CPHI Milan 2024: Compliance and Automation in Aseptic Processing